Astera Labs (ALAB) presents a strongly positive liquidation recovery posture for an asset-light semiconductor IP company, driven primarily by a large liquid asset base that materially exceeds its modest liability stack. As of March 31, 2026, total assets are $1.66B against total liabilities of $165M, yielding reported stockholders' equity of $1.49B. Under liquidation haircuts, the recovery picture remains positive: cash and cash equivalents of $148M recover at par; marketable securities (available-for-sale debt securities) of $1.04B recover near par given their liquid, short-duration nature; accounts receivable of $135M recover at 90-95% (~$121-128M). Inventory of $60M (split roughly $47M WIP, $13M finished goods, $0.3M raw materials) recovers at 60% (~$36M), with WIP concentration slightly reducing realizable value. PP&E gross of $113M less accumulated depreciation of $15M yields net $97M, recovering at 50-70% (~$49-68M); notably, a substantial portion of gross PP&E likely represents production equipment and lab assets that could carry reasonable liquidation bids in the current semiconductor demand environment. Intangibles are not separately tagged in XBRL for this period beyond goodwill of $88M, which carries zero liquidation value. Other noncurrent assets of $61M (likely prepaid R&D tools, deposits, deferred tax assets) recover at minimal or zero value. On the liability side, all obligations are taken at face: current liabilities of $125M (AP $56M, accrued liabilities $69M including employee-related $23M and other accrued $31M) plus noncurrent liabilities of $40M, plus operating lease liability of $42M total ($52.7M undiscounted future payments under ASC 842). Total operating lease undiscounted commitment of $52.7M ($10.8M excess amount) represents a real wind-down obligation. Unrecorded purchase commitments of $14.8M (software licenses, cloud services) are disclosed in MD&A but not separately tagged as a balance-sheet liability in XBRL—these would become immediately payable or subject to break fees in a liquidation scenario. A business acquisition closed in Q1 2026 for $65M cash produced $88M of goodwill, implying a negative implied tangible value pickup. The MFFAIS CLV is -$12.9M (cash basis), LLV is $121.9M, and OLV is $182M. These are consistent with a going-concern that retains meaningful net liquidation value at the liquid-asset level, but where intangible and goodwill write-downs largely erode any premium over reported book. The prior filing (10-K, December 31, 2025) does not provide directly comparable balance-sheet figures in the truncated body provided, but the investing cash flow disclosure shows a $65M acquisition and $88M goodwill creation as new items in Q1 2026, incrementally worsening the liquidation recovery versus year-end 2025.
▼ Community Notes